​

Funding Round

Series B - Octave

Series B - Octave

Investment Firm

Overview

Octave is a biotechnology company that uses precision medicine and scientific insights to treat patients with multiple sclerosis.

Announced Date

Jul 26, 2023

Funding Type

Series B

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

N/A

Participant Investors

9

Investor Name
Participant InvestorMerck Global Health Innovation Fund
Participant InvestorEcho Health Ventures
Participant InvestorDeerfield
Participant InvestorSection 32
Participant InvestorNovartis

Round Details and Background

Octave raised $32500070 on 2023-07-26 in Series B

Octave is a biotechnology company that uses precision medicine and scientific insights to treat patients with multiple sclerosis.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 17, 2020
Series B - Octave
5-32.0M
Oct 11, 2021
Venture Round - Octave
1-undefined
Jul 26, 2023
Series B - Octave
10-32.5M
Nov 15, 2023
Grant - Octave
1-10.0M

Recent Activity

There is no recent news or activity for this profile.